每年專案
個人檔案
學歷
- 1992 臺北醫學大學藥學博士
- 1985 臺北醫學大學藥學碩士
- 1983 臺北醫學大學藥學學士
經歷
- 2012 臺北醫學大學藥物科學學科教授
- 2003-2012 臺北醫學大學藥學系教授
研究興趣
- 藥物分析
- 藥物傳遞系統
指紋
查看啟用 Hsiu-O Ho 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
- 1 類似的個人檔案
網路
國家/地區層面的近期外部共同作業。按一下圓點深入探索詳細資料，或
-
開發熱安定性醣化PLGA奈米顆粒負載以SARS-CoV-2 spike protein編碼的mRNA作為新型冠狀病毒疫苗之研究
8/1/22 → 7/31/23
研究計畫: A - 政府部門 › b - 科技部
-
發展可標靶樹突細胞之mPEG-PLGA/PLGA-PEG-PLGA混和水膠體的奈米顆粒癌症疫苗用於癌症免疫療法(3/3)
8/1/21 → 7/31/22
研究計畫: A - 政府部門 › b - 科技部
-
-
發展可標靶樹突細胞之mPEG-PLGA/PLGA-PEG-PLGA混和水膠體的奈米顆粒癌症疫苗用於癌症免疫療法(1/3)
8/1/19 → 7/31/20
研究計畫: A - 政府部門 › b - 科技部
-
-
Synergistic Combination of Irinotecan and Rapamycin Orally Delivered by Nanoemulsion for Enhancing Therapeutic Efficacy of Pancreatic Cancer
Liu, Y. H., Chen, L. C., Cheng, W. T., Wei, P. S., Hsieh, C. M., Sheu, M. T., Lin, S. Y., Ho, H. O. & Lin, H. L., 2月 2023, 於: Pharmaceutics. 15, 2, 473.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Bispecific T-cell engagers non-covalently decorated drug-loaded PEGylated nanocarriers for cancer immunochemotherapy
Cheng, W. J., Chuang, K. H., Lo, Y. J., Chen, M., Chen, Y. J., Roffler, S. R., Ho, H. O., Lin, S. Y. & Sheu, M. T., 4月 2022, 於: Journal of Controlled Release. 344, p. 235-248 14 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
4 引文 斯高帕斯（Scopus） -
Combined Docetaxel/Pictilisib-Loaded mPEGylated Nanocarriers with Dual HER2 Targeting Antibodies for Synergistic Chemotherapy of Breast Cancer
Cheng, W. J., Lin, S. Y., Chuang, K. H., Chen, M., Ho, H. O., Chen, L. C., Hsieh, C. M. & Sheu, M. T., 2022, 於: International Journal of Nanomedicine. 17, p. 5353-5374 22 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Glycosylation of OVA antigen-loaded PLGA nanoparticles enhances DC-targeting for cancer vaccination
Chou, P. Y., Lin, S. Y., Wu, Y. N., Shen, C. Y., Sheu, M. T. & Ho, H. O., 11月 2022, 於: Journal of Controlled Release. 351, p. 970-988 19 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
4 引文 斯高帕斯（Scopus） -
Active Tumoral/Tumor Environmental Dual-Targeting by Non-Covalently Arming with Trispecific Antibodies or Dual-Bispecific Antibodies on Docetaxel-Loaded mPEGylated Nanocarriers to Enhance Chemotherapeutic Efficacy and Minimize Systemic Toxicity
Cheng, W. J., Lin, S. Y., Chen, M., Chen, L. C., Ho, H. O., Chuang, K. H. & Sheu, M. T., 2021, 於: International Journal of Nanomedicine. 16, p. 4017-4030 14 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取4 引文 斯高帕斯（Scopus）
資料集
-
Novel application of pluronic lecithin organogels (PLOs) for local delivery of synergistic combination of docetaxel and cisplatin to improve therapeutic efficacy against ovarian cancer
Chang, C. (Contributor), Hsieh, C. (Contributor), Chen, L. (Contributor), Su, C. (Contributor), Liu, D. (Contributor), Jhan, H. (Contributor), Ho, H. (Contributor) & Sheu, M. (Contributor), Unknown Publisher, 1月 1 2018
DOI: 10.6084/m9.figshare.5908795.v1, https://tandf.figshare.com/articles/Novel_application_of_pluronic_lecithin_organogels_PLOs_for_local_delivery_of_synergistic_combination_of_docetaxel_and_cisplatin_to_improve_therapeutic_efficacy_against_ovarian_cancer/5908795/1
資料集: Dataset
-
Novel application of pluronic lecithin organogels (PLOs) for local delivery of synergistic combination of docetaxel and cisplatin to improve therapeutic efficacy against ovarian cancer
Hsieh, C. (Contributor), Chen, L. (Contributor), Liu, D. (Contributor), Ho, H. (Contributor), Su, C. (Contributor), Sheu, M. (Contributor), Jhan, H. (Contributor) & Chang, C. (Contributor), Unknown Publisher, 2018
DOI: 10.6084/m9.figshare.5908795, https://doi.org/10.6084%2Fm9.figshare.5908795
資料集: Dataset
-
Bispecific antibodies (anti-mPEG/anti-HER2) for active tumor targeting of docetaxel (DTX)-loaded mPEGylated nanocarriers to enhance the chemotherapeutic efficacy of HER2-overexpressing tumors
Su, C. (Contributor), Chen, M. (Contributor), Chen, L. (Contributor), Ho, Y. (Contributor), Ho, H. (Contributor), Lin, S. (Contributor), Chuang, K. (Contributor) & Sheu, M. (Contributor), Unknown Publisher, 5月 2 2018
DOI: 10.6084/m9.figshare.6213620.v1, https://tandf.figshare.com/articles/Bispecific_antibodies_anti-mPEG_anti-HER2_for_active_tumor_targeting_of_docetaxel_DTX_-loaded_mPEGylated_nanocarriers_to_enhance_the_chemotherapeutic_efficacy_of_HER2-overexpressing_tumors/6213620/1
資料集: Dataset
-
Bispecific antibodies (anti-mPEG/anti-HER2) for active tumor targeting of docetaxel (DTX)-loaded mPEGylated nanocarriers to enhance the chemotherapeutic efficacy of HER2-overexpressing tumors
Chen, L. (Contributor), Lin, S. (Contributor), Sheu, M. (Contributor), Ho, Y. (Contributor), Su, C. (Contributor), Chen, M. (Contributor), Ho, H. (Contributor) & Chuang, K. (Contributor), Unknown Publisher, 2018
DOI: 10.6084/m9.figshare.6213620, https://doi.org/10.6084%2Fm9.figshare.6213620
資料集: Dataset